2007
DOI: 10.1038/sj.onc.1210276
|View full text |Cite
|
Sign up to set email alerts
|

Mutant p53: from guardian to fallen angel?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 5 publications
1
6
0
Order By: Relevance
“…Hence, our observations provide an explanation for the important question why p53 mutations rather than p53 deletions arise in tumors (Deppert, 2007;Soussi and Wiman, 2007). Consistent with this, it was found that chemotherapeutics, hypoxia and oncogene activation induce checkpoint activation, replicational arrest and selection for aberrant p53 (Hanahan and Weinberg, 2000;Janssens and Tschopp, 2006;Finkel et al, 2007;Marusyk and DeGregori, 2007;Kra¨mer, 2009;Viale et al, 2009).…”
Section: Control Of Activated Nf-jb By P53supporting
confidence: 67%
See 1 more Smart Citation
“…Hence, our observations provide an explanation for the important question why p53 mutations rather than p53 deletions arise in tumors (Deppert, 2007;Soussi and Wiman, 2007). Consistent with this, it was found that chemotherapeutics, hypoxia and oncogene activation induce checkpoint activation, replicational arrest and selection for aberrant p53 (Hanahan and Weinberg, 2000;Janssens and Tschopp, 2006;Finkel et al, 2007;Marusyk and DeGregori, 2007;Kra¨mer, 2009;Viale et al, 2009).…”
Section: Control Of Activated Nf-jb By P53supporting
confidence: 67%
“…Inactivation of the p53 pathway is observed in most human cancers, with mutations in p53 occurring in at least 50% of all tumors (Soussi and Wiman, 2007). Interestingly, in addition to the lack of tumor suppressive functions, p53 mutants gain oncogenic activities contributing to carcinogenesis and drug resistance (Moll et al, 2005;Deppert, 2007;Vousden and Lane, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Because the expression of mutant p53 in tumor cells has been associated with increased cell proliferation and survival (38,39), we sought to analyze the effect of PAs on cell cycle and apoptosis of two cancer cell lines (Sk-Br-3 and MDA-MB-468) bearing endogenous mutant p53 (respectively, p53R175H and p53R273H). To selectively analyze cells expressing the PAs, propidium-iodide staining was measured only in the EGFP-positive cell population.…”
Section: Pas Interfere With Mutant P53 Transactivating Functionsmentioning
confidence: 99%
“…Stable 3T3mutp53 C2 and C6 clones were maintained in DMEM supplemented with 5% FCS and 200 mg/ml G418 (Gibco). Cells were grown to subconfluent monolayers in 100 mm 2 dishes and infected with SV40 virus (strain 776) at a multiplicity of infection (MOI) of one, as previously described (Tiemann and Deppert, 1994). Virus incubation (2 h) at 371C continued altogether in complete medium for 34 h postinfection.…”
Section: Cells and Abortive Infectionmentioning
confidence: 99%